<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Atossa Genetics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven C. Quay, MD, PhD
    • FOUNDED
      2009
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    Bio-Techne Corp

    Bio-Techne Corp

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of h...

    Bio-Techne Corporation (NASDAQ: TECH) is a lead...

    Filing Type:    PU
    Aerpio Pharmaceuticals, Inc.

    Aerpio Pharmaceuticals, Inc.

    Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-i...

    Aerpio Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    Eyegate Pharmaceuticals, Inc.

    Eyegate Pharmaceuticals, Inc.

    EyeGate is developing and commercializing products for treating diseases and disor...

    EyeGate is developing and commercializing produ...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...

    Oncolytics is focused on obtaining regulatory a...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.